Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.68, with a market capitalisation of $2.02M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.58 to $55.90. This page covers its latest market performance, valuation, price trends and company information.
$2.02M | |
$3.44 | |
$252,520.00 | |
$2.58 | |
$3.53 | |
3.19K | |
2.11M | |
-- | |
$55.90 | |
$2.58 | |
-- | |
-- |
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is trading at $3.68 in pre-market trading as of 2026-09-16 10:29:00, up 4.16% ($0.15) from the previous close of $3.53
Pre-market trading shows how investors are pricing SHPH before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) moved from $3.50 to $3.68, representing a gain of 5.09% ($0.18).
The stock traded between $3.40 and $3.76 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 12.58 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.1%
SHPH is currently trading at $3.68, placing it 2.1% of the way from its 52-week low of $2.58 to its 52-week high of $55.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.